Hopfinger, Georg
Worel, Nina
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 1 September 2019
Accepted: 10 December 2019
First Online: 24 January 2020
Conflict of interest
: G. Hopfinger has received honoraria from Celgene, Gilead, GlaxoSmithKline, Janssen, Novartis, Roche, Takeda, and received research funding from Gilead. N. Worel has received honoraria from AOP Orphan, Celgene, Gilead, Jazz, Novartis, Therakos Mallinckrodt Pharmaceuticals, Sanofi Genzyme, and received research funding from Therakos Mallinckrodt Pharmaceuticals, and Sanofi Genzyme.